Skip to content

THAR

Canton Strategic Holdings, Inc.

NASDAQ · Healthcare · Biotechnology · US

$3.54
+6.63%
Ask drillr

Latest reported

Last report date
Mar 24, 2026
EPS actual
-$2.02
EPS estimate
-$0.42
Revenue actual
—
Revenue estimate
—

Track record

Trailing twelve quarters

EPS beats (12Q)
2
EPS misses (12Q)
4
EPS in line (12Q)
1
Avg surprise (4Q)
-100.6%
Revenue beats (12Q)
—
Earnings call history

No earnings call summaries available

Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Mar 24, 2026-$0.42-$2.02Miss -380.95%—
Nov 12, 2025-$0.43-$0.34Beat 20.93%—
Aug 14, 2025-$0.58-$0.64Miss -10.34%—
Mar 25, 2025-$1.53-$2.02Miss -32.03%—
Nov 7, 2024—-$2.45——
Aug 9, 2024—-$2.42——
May 9, 2024—-$2.85——
Mar 21, 2024-$1.25-$0.71Beat 43.20%—
Aug 11, 2023-$0.16-$0.16In line—
May 22, 2023-$0.11-$0.23Miss -109.09%—
Mar 31, 2021—-$75——
Dec 31, 2020—-$45——

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 16, 2026